Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

10.5K
A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
10.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of potent and selective small molecule TALK-1 inhibitors that promote β-cell function.

Molecular pharmacology·2026
Same author

Discovery of VU6053371/BI03738809: A First-in-Class Selective and CNS-Penetrant mGlu<sub>3</sub> Positive Allosteric Modulator (PAM) with Efficacy in a Preclinical Cognition Model.

ACS chemical neuroscience·2026
Same author

A mouse model to study persistent fatigue.

Research square·2026
Same author

Design, synthesis and evaluation of novel BRD4 and RIPK3 dual inhibitors as potential anti-inflammatory agents and antidotes for arsenicals.

Bioorganic & medicinal chemistry letters·2026
Same author

Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutations.

Molecular therapy. Oncology·2026
Same author

Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitors.

Bioorganic & medicinal chemistry letters·2025

Related Experiment Video

Updated: Jul 11, 2025

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

26.3K

High-Throughput cell-based immunofluorescence assays against influenza.

Yohanka Martinez-Gzegozewska1, Lynn Rasmussen1, Sara McKellip1

  • 1Scientific Platforms Division, Southern Research, High-Throughput Screening Center, Birmingham, Alabama, United States.

SLAS Discovery : Advancing Life Sciences R & D
|November 4, 2023
PubMed
Summary

A new high-throughput assay using human A549 cells identifies influenza virus inhibitors. This method also assesses neutralizing antibodies without trypsin, aiding rapid drug discovery for influenza pandemics.

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.8K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

Related Experiment Videos

Last Updated: Jul 11, 2025

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

26.3K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.8K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

Area of Science:

  • Virology
  • Drug Discovery
  • Cell Biology

Background:

  • Influenza outbreaks pose significant public health risks, necessitating rapid development of effective antiviral drugs.
  • Current drug discovery methods often rely on non-human cell lines (MDCK), limiting direct translation to human therapies.
  • Limited approved antiviral agents exist, highlighting the need for improved screening platforms.

Purpose of the Study:

  • To develop a sensitive, high-throughput cell-based assay for identifying inhibitors of influenza A and B viruses.
  • To optimize the assay for assessing the neutralizing capacity of antibodies, including purified antibodies and serum samples.
  • To establish a versatile platform for both initial high-throughput screening and later-stage quantitative potency determination.

Main Methods:

  • Utilized the human A549 cell line for a cell-based imaging assay to detect viral cytopathic effects.
  • Developed a high-throughput compatible assay for screening influenza virus inhibitors.
  • Optimized the assay to evaluate antibody neutralization in the absence of trypsin.

Main Results:

  • Successfully developed a sensitive, high-throughput compatible assay using the human A549 cell line.
  • The assay effectively identifies inhibitors of both influenza A and B viruses.
  • Demonstrated the assay's capability to assess antibody neutralization without trypsin, enabling testing of various antibody preparations.

Conclusions:

  • The developed assay provides a robust platform for rapid identification of anti-influenza drugs using human cells.
  • This assay facilitates efficient screening for potential pandemic influenza therapeutics.
  • The platform supports both broad screening and detailed structure-activity relationship studies for antiviral drug development.